Antibody Therapeutics Inc. has disclosed integrin receptor antagonists reported to be useful for the treatment of pulmonary fibrosis, renal fibrosis and hepatic fibrosis.

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

Lilly has also submitted marketing applications for Mirikizumab-mrkz in Crohn’s disease around the globe, including in the ...

Figure 1: Cell-binding assays with a defined α v integrin phage ligand and phage ... Binding of the CPQPRPLC peptide to immobilized VEGF receptors. Our results show that organic phase separation ...

Biologics work by targeting proteins that cause inflammation in ulcerative colitis. As a result, certain biologics help ...

ORLANDO -- Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes in patients with ulcerative colitis previously untreated with a biologic, but the integrin receptor ...